Resources
About Us
Home Report
Store
Autoimmune Disease Diagnostics Market
Autoimmune Disease Diagnostics Market Size, Share, Forecast, & Trends Analysis By Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized) - Global Forecast to 2031
Report ID:MRHC - 104721 Pages: 260 Oct-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursAutoimmune Disease Diagnostics Market Size & Forecast
The Autoimmune Disease Diagnostics Market is projected to reach $10.55 billion by 2031, at a CAGR of 7.2% in the forecast period of 2024–2031. The growth of the autoimmune disease diagnostics market is driven by the increasing prevalence of autoimmune disorders, the growing emphasis on early diagnosis, and the rising awareness regarding autoimmune diseases. However, difficulties in diagnosing autoimmune diseases restrain the growth of this market. Emerging economies and increasing investments & funding in the autoimmune diseases space are expected to generate growth opportunities for the players in this market. However, the unfavorable reimbursement scenario and high rate of delayed diagnosis or misdiagnosis are major challenges for market growth.
Autoimmune Disease Diagnostics Market Growth Drivers
Rising Awareness About Autoimmune Diseases
Stress, genetic mutations, unhealthy eating habits, and environmental factors are among the primary causes of autoimmune diseases. The high prevalence of these conditions worldwide has increased the demand for autoimmune disease diagnostics. For instance, the CDC's National Diabetes Statistics Report of 2020 indicates that approximately 1.4 million people in the U.S. have Type 1 diabetes, with this number projected to rise to 2.1 million by 2040.
Furthermore, growing awareness about the diagnosis and treatment of autoimmune diseases, driven by initiatives from various public and private organizations, has contributed to this demand. For example, the Autoimmune Association in the U.S. conducts events and campaigns every March to raise awareness, disseminate information, and enhance knowledge about autoimmune disorders.
Early diagnosis of autoimmune diseases is crucial for reducing disability, morbidity, and mortality, which is fueling the growth of the autoimmune disease diagnostics market.
Click here to: Get Free Sample Pages of this Report
Autoimmune Disease Diagnostics Market Trends
Use of Biosensors for Detection of Autoimmune Diseases
Biosensors are analytical devices that utilize biological elements, measurement devices, and a transducer to detect specific substances. In the context of autoimmune diseases, biosensors are employed for diagnostic applications based on the detection of highly specific biomarkers, using antigens, peptides, and antibodies as recognition elements.
In the field of autoimmune diseases, biosensors can diagnose diseases by detecting specific biomarkers through antibodies (Abs), antigens (Ags), and peptides. Research indicates that biomarkers exhibit different specificities in autoimmune diseases; some biomarkers are associated with multiple diseases, while others are disease-specific. Among these biomarkers, autoantibodies (AAbs) are considered the most effective diagnostic biomarkers due to their significant role in the pathogenic process of disease development. AAbs are particularly valuable for diagnosis, monitoring, and assessing disease severity due to their specificity and stability during illness.
In addition to AAbs, other biomarkers such as chemokines, cytokines, and proteins are also utilized for diagnosing autoimmune diseases, offering the potential for various diagnostic applications.
Several research efforts are focused on developing biosensors for autoimmune disease diagnosis. These biosensors provide rapid, sensitive, and cost-effective diagnostic solutions, enhancing analytical performance. Commonly used biosensors for autoimmune disease diagnostics include those based on electrochemical detection, as well as piezoelectric and optical biosensors. These advancements are expected to improve the diagnostic outcomes of autoimmune diseases, paving the way for new product segments in the autoimmune disease diagnostics market in the future.
Autoimmune Disease Diagnostics Market Opportunities
Developing Countries
Developed countries have a higher market penetration rate for autoimmune disease diagnostics than developing countries, primarily due to higher diagnosis rates. According to the hygiene hypothesis, children in developed countries, who are less exposed to diverse microbial challenges compared to children from developing countries, have altered immune homeostasis, increasing their risk for several immune-mediated diseases. This hypothesis is supported by epidemiological data, especially migration studies, which show that individuals migrating from low-incidence to high-incidence countries acquire immune disorders.
In developing countries, the adoption of unhealthy lifestyles has been on the rise due to increasing urbanization, fast food consumption, reduced physical activity, stress, and other factors. These lifestyle changes are contributing to the growing incidence of autoimmune diseases in these regions. For instance, according to the National Institute of Environmental Health Sciences (U.S.), as of 2022, approximately 24 million people in the U.S. suffer from autoimmune diseases, making these conditions one of the leading causes of death and disability in the country.
Autoimmune Disease Diagnostics Market Analysis: Key Findings
By Product Type: In 2024, the Reagents, Assays, & Kits Segment is Expected to Dominate the Autoimmune Disease Diagnostics Market
Based on product type, the autoimmune disease diagnostics market is segmented into reagents, assays, & kits; software & services; and instruments. In 2024, the reagents, assays, & kits segment is expected to account for the largest share of 84.0% of the autoimmune disease diagnostics market. The large market share of this segment is attributed to factors such as the high diagnosis rate of autoimmune diseases in developed countries coupled with the recurring purchase of reagents and kits.
Similarly, the growing availability of assays and kits, convenience & ease of use, cost-effectiveness, and product launches by the players operating in the market are the factors driving the growth of the segment at the highest CAGR of 7.4% during the forecast period of 2024 to 2031.
By Test Type: In 2024, the Antinuclear Antibodies (ANA) Segment is Expected to Dominate the Autoimmune Disease Diagnostics Market
Based on test type, the autoimmune disease diagnostics market is segmented into antinuclear antibodies test (ANA), C-reactive protein test (CRP), erythrocyte sedimentation rate test, rheumatoid factor test, immunoglobulins test, routine blood tests, and other test types. In 2024, the antinuclear antibodies (ANA) segment is expected to account for the largest share of the autoimmune disease diagnostics market. Antinuclear antibodies (ANA) tests detect autoantibodies in the blood that target healthy cells. These antibodies often appear well before the onset of symptoms, enabling the early diagnosis of autoimmune diseases. Early detection through ANA tests can significantly reduce morbidity and mortality associated with these conditions. Consequently, the high prevalence of autoimmune diseases and the critical need for early diagnosis are key factors driving the significant market share of this segment.
Additionally, the antinuclear antibodies (ANA) segment is expected to register the highest CAGR of 8.3% during the forecast period. The advantages of the ANA test, including sensitivity, early detection of autoimmune disease, and the most preferred test for primary detection of autoimmune diseases, are the factors responsible for segment growth.
By Disease Type: In 2024, the Systemic Autoimmune Diseases Segment is Expected to Dominate the Autoimmune Disease Diagnostics Market
Based on disease type, the autoimmune disease diagnostics market is segmented into systemic autoimmune diseases and organ-specific autoimmune diseases. In 2024, the systemic autoimmune diseases segment is expected to account for the larger share of the autoimmune disease diagnostics market. Systemic autoimmune diseases impact multiple organs or systems, in contrast to localized autoimmune diseases, which target a specific organ or region of the body. Some of the most prevalent autoimmune diseases are systemic, such as rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus (SLE). For example, according to the World Health Organization, approximately 14 million people worldwide had rheumatoid arthritis as of 2021. The high prevalence of systemic autoimmune diseases is a key factor contributing to the significant share of this segment.
Moreover, the systemic autoimmune diseases segment is expected to grow at the highest CAGR during the forecast period of 2024-2031. This growth is attributed to the growing prevalence of systemic autoimmune diseases and the growing availability of diagnostic tests for systemic autoimmune diseases.
By End User: In 2024, the Diagnostic Laboratories Segment is Expected to Dominate the Autoimmune Disease Diagnostics Market
Based on end user, the autoimmune disease diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, and academic & research institutes. In 2024, the diagnostic laboratories segment is expected to account for the largest share of the autoimmune disease diagnostics market. The large market share of this segment is attributed to the presence of skilled professionals, the capacity to process numerous samples efficiently, and the availability of well-equipped systems and instruments in diagnostics laboratories.
Diagnostic labs are well equipped with a skilled workforce to conduct diagnostic testing. Additionally, these labs have instruments and systems required to carry out testing and can run multiple samples in a short amount of time. Therefore, patients and healthcare professionals prefer diagnostic labs, leading to a large share of the segment.
However, the hospitals & clinics segment is slated to register the highest CAGR during the forecast period of 2024-2031. The growth of this segment is attributed to the growing adoption of point-of-care testing in hospitals, initiatives undertaken by the hospitals to expand diagnostic capabilities, and rising prevalence and awareness regarding autoimmune diseases coupled with hospitals & clinics being the first point of contact for patients.
Geographical Analysis
In 2024, North America is expected to account for the largest share of 39.6% of the global autoimmune disease diagnostics market. This large share of North America is attributed to the high prevalence of autoimmune diseases, technological advancements in diagnostics, the presence of key players, and high healthcare expenditure in the region.
However, Asia-Pacific is slated to register the highest growth rate of 9.7% in the autoimmune disease diagnostics market during the forecast period. The high market growth in the Asia-Pacific region is attributed to the increasing prevalence and incidence of celiac disease and rheumatoid arthritis, unhealthy lifestyles, government initiatives addressing autoimmune diseases, and rising expenditure on autoimmune disease research. Autoimmune diseases are becoming more prevalent in the Asia-Pacific region. For example, psoriasis is one of the most common autoimmune skin conditions globally. According to the Global Psoriasis Atlas, around 3.59 million people in India have psoriasis, a number that is expected to rise.
Autoimmune Disease Diagnostics Key Companies
The report includes a competitive landscape based on an extensive assessment of product portfolio, test type, disease type, end user, geographic presence, and the key growth strategies adopted by leading market players in the industry over the past years. The key players profiled in the autoimmune disease diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Grifols, S.A. (Spain), and Creative Diagnostics (U.S.).
Autoimmune Disease Diagnostics Market Industry Overview: Latest Developments from Key Industry Players
- In June 2023, EUROIMMUN Medizinische Labordiagnostika AG (Germany) launched a new automated indirect immunofluorescence test (IIFT) system, ‘UNIQO 160’. This system is used for the diagnosis of autoimmune diseases.
- In May 2022, Thermo Fisher Scientific, Inc. (U.S.) launched an EliA-based instrument named Phadia 2500+. This system diagnoses autoimmune diseases, including connective tissue disease, antiphospholipid syndrome, celiac disease, rheumatoid arthritis, autoimmune liver disease, and autoimmune thyroid disease.
- In December 2021, Grifols, S.A. (Spain) received its first European Union (EU) Technical Documentation Assessment and Quality Management System certificates under the In Vitro Diagnostics Medical Devices Regulation (IVDR) from EU-designated notified bodies under the new regulation. The company has received IVDR certifications for several products for immunohematology blood typing and detection of anti-erythrocyte antibodies, such as DG Gel cards, antisera, reagent red blood cells and ID HPA XT test, a human platelet antigen (HPA) genotyping assay.
Autoimmune Disease Diagnostics Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
260 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
7.2% |
|
Market Size (Value) |
USD 10.55 Billion by 2031 |
|
Segments Covered |
By Product Type
By Test Type
By Disease Type
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa |
|
Key Companies |
Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Grifols, S.A. (Spain), and Creative Diagnostics (U.S.). |
Key questions answered in the autoimmune disease diagnostics market report:
The Autoimmune Disease Diagnostics Market refers to the industry focused on developing, manufacturing, and providing diagnostic tools and tests used to detect and diagnose autoimmune diseases.
The market is projected to reach $10.55 billion by 2031.
The market is expected to grow at a CAGR of 7.2% from 2024 to 2031, reaching $10.55 billion by 2031.
As of 2024, the market is growing toward its projected value of $10.55 billion by 2031
Key players in this market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Becton, Dickinson, and Company, PerkinElmer, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers AG,
A key market trend is the increased use of biosensors for detecting autoimmune diseases. These biosensors provide rapid, cost-effective diagnostic solutions by using biomarkers like antibodies and proteins to detect specific autoimmune diseases.
Major drivers include:
- Rising prevalence of autoimmune diseases such as Type 1 diabetes and rheumatoid arthritis.
- Increased awareness and emphasis on early diagnosis.
- Product type: Reagents, Assays, & Kits; Software & Services; Instruments.
- Test type: Antinuclear Antibodies (ANA), C-Reactive Protein (CRP), Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor, and others.
- Disease type: Systemic Autoimmune Diseases, Organ-Specific Autoimmune Diseases.
The global outlook is promising, with the market projected to grow significantly, driven by increased demand for early diagnostic solutions, rising autoimmune disease cases globally, and growing investments in diagnostic technologies.
The market is expected to grow at a CAGR of 7.2% during the forecast period (2024–2031)
The market is projected to grow at a CAGR of 7.2% from 2024 to 2031.
???????North America holds the largest market share, accounting for 39.6% in 2024, due to the high prevalence of autoimmune diseases, advanced diagnostic technologies, and significant healthcare spending.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process Of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Increasing Prevalence of Autoimmune Disorders Driving Growth in Diagnostic Testing
4.2.1.2. Rising Awareness Regarding Autoimmune Diseases Boosting the Adoption of Diagnostic Products
4.2.1.3. Increasing Investments & Funding in The Autoimmune Diseases Space Generating Market Growth Opportunities
4.2.2. Factor Analysis
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Buyers
4.3.2. Bargaining Power of Suppliers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Degree of Competition
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. China
4.4.3.2. India
4.4.3.3. Japan
4.4.4. Latin America
4.4.5. Middle East & Africa
5. Autoimmune Disease Diagnostics Market Assessment— by Product Type
5.1. Overview
5.2. Reagents, Kits, & Assays
5.3. Instruments
5.4. Software & Services
6. Autoimmune Disease Diagnostics Market Assessment— by Test Type
6.1. Overview
6.2. Antinuclear Antibodies (ANA) Test
6.3. C-Reactive Protein Test
6.4. Erythrocyte Sedimentation Rate Test
6.5. Rheumatoid Factor Test
6.6. Immunoglobulins Test
6.7. Routine Blood Test
6.8. Other Autoimmune Tests
7. Global Autoimmune Disease Diagnostics Market— by Disease Type
7.1. Overview
7.2. Systemic Autoimmune Diseases
7.2.1. Rheumatoid Arthritis
7.2.2. Psoriasis
7.2.3. Systemic Lupus Erythematosus
7.2.4. Multiple Sclerosis
7.2.5. Other Systemic Autoimmune Diseases
7.3. Organ-specific Autoimmune Diseases
7.3.1. Type-1 Diabetes
7.3.2. Celiac Disease
7.3.3. Inflammatory Bowel Diseases
7.3.4. Other Organ-specific Autoimmune Diseases
8. Autoimmune Disease Diagnostics Market Assessment— by End User
8.1. Overview
8.2. Diagnostic Laboratories
8.3. Hospitals & Clinics
8.4. Academic & Research Institutes
9. Autoimmune Disease Diagnostics Market Assessment— by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. Italy
9.3.4. Spain
9.3.5. France
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
11.1. Abbott Laboratories
11.2. F. Hoffmann-La Roche Ltd.
11.3. Siemens Healthineers AG (A Subsidiary of Siemens AG)
11.4. Thermo Fisher Scientific, Inc.
11.5. Bio-Rad Laboratories, Inc.
11.6. Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
11.7. Becton, Dickinson and Company
11.8. PerkinElmer, Inc.
11.9. Grifols, S.A.
11.10. Creative Diagnostics
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Autoimmune Disease Diagnostics Market, by Product Type, 2022-2031 (USD Million)
Table 2 Global Autoimmune Disease Diagnostics Market for Reagents, Kits, And Assays, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Autoimmune Disease Diagnostics Market for Instruments, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Autoimmune Disease Diagnostics Market for Software & Services, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 6 Global Antinuclear Antibodies (ANA) Test Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global C-Reactive Protein Test Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Erythrocyte Sedimentation Rate Test Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Rheumatoid Factor Test Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Immunoglobulin Test Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Routine Blood Test Market, by Country/Region, 2022–2031 (USD Million)
Table 12 Global Other Autoimmune Test Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 14 Global Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 15 Global Systemic Autoimmune Disease Diagnostics Market by Country/Region, 2022–2031 (USD Million)
Table 16 Global Rheumatoid Arthritis Diagnostics Market by Country/Region, 2022–2031 (USD Million)
Table 17 Global Psoriasis Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Systemic Lupus Erythematosus Diagnostics Market by Country/Region, 2022–2031 (USD Million)
Table 19 Global Multiple Sclerosis Diagnostics Market by Country/Region, 2022–2031 (USD Million)
Table 20 Global Other Systemic Autoimmune Diseases Diagnostics Market by Country/Region, 2022–2031 (USD Million)
Table 21 Global Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 22 Global Organ-specific Autoimmune Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Type-1 Diabetes Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Celiac Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Research Studies for Crohn's Disease and Ulcerative Colitis in Canada
Table 26 Global Inflammatory Bowel Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Other Organ-specific Autoimmune Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 29 Global Autoimmune Disease Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Autoimmune Disease Diagnostics Market for Hospitals & Clinics, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Autoimmune Disease Diagnostics Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Autoimmune Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 33 North America: Autoimmune Disease Diagnostics Market, by Country, 2022–2031 (USD Million)
Table 34 North America.: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 35 North America.: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 36 North America.: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 37 North America: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 38 North America: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 39 North America: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 40 U.S.: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 41 U.S.: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 42 U.S.: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 43 U.S.: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 44 U.S.: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 45 U.S.: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 46 Canada: Arthritis Prevalence, 2018—2021
Table 47 Canada: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 48 Canada: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 49 Canada: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 50 Canada: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 51 Canada: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 52 Canada: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 53 Europe: Autoimmune Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 54 Europe: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 55 Europe: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 56 Europe: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 57 Europe: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 58 Europe: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 59 Europe: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 60 Germany: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 61 Germany: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 62 Germany: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 63 Germany: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 64 Germany: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 65 Germany: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 66 U.K.: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 67 U.K.: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 68 U.K.: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 69 U.K.: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 70 U.K.: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 71 U.K.: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 72 Italy: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 73 Italy: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 74 Italy: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 75 Italy: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 76 Italy: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 77 Italy: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 78 Spain: Number of People with Type 1 Diabetes (2022)
Table 79 Spain: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 80 Spain: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 81 Spain: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 82 Spain: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 83 Spain: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 84 Spain: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 85 France: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 86 France: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 87 France: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 88 France: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 89 France: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 90 France: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 91 Rest of Europe: Number of People with Type 1 Diabetes, 2022
Table 92 RoE: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 93 RoE: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 94 RoE: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 95 RoE: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 96 RoE: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 97 RoE: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 98 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Country/Region, 2022–2031 (USD Million)
Table 99 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 100 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 101 Asia-Pacific: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 102 Asia-Pacific: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 103 Asia-Pacific: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 104 Asia-Pacific: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 105 China: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 106 China: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 107 China: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 108 China: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 109 China: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 110 China: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 111 Comparison of Type 1 Diabetes in Asia-Pacific Countries (2022)
Table 112 India: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 113 India: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 114 India: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 115 India: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 116 India: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 117 India: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 118 Japan: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 119 Japan: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 120 Japan: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 121 Japan: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 122 Japan: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 123 Japan: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 124 RoAPAC: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 125 RoAPAC: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 126 RoAPAC: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 127 RoAPAC: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 128 RoAPAC: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 129 RoAPAC: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 130 Latin America: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 131 Latin America: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 132 Latin America: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 133 Latin America: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 134 Latin America: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 135 Latin America: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 136 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Product Type, 2022–2031 (USD Million)
Table 137 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Test Type, 2022–2031 (USD Million)
Table 138 Middle East & Africa: Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 139 Middle East & Africa: Systemic Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 140 Middle East & Africa: Organ-specific Autoimmune Disease Diagnostics Market, by Disease Type, 2022–2031 (USD Million)
Table 141 Middle East & Africa: Autoimmune Disease Diagnostics Market, by End User, 2022–2031 (USD Million)
Table 142 Recent Developments, by Company, 2021–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Autoimmune Disease Diagnostics Market Size, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global Autoimmune Disease Diagnostics Market Size, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Autoimmune Disease Diagnostics Market Size, by Disease Type, 2024 Vs. 2031 (USD Million)
Figure 10 Global Autoimmune Disease Diagnostics Market Size, by End User, 2024 Vs. 2031 (USD Million)
Figure 11 Autoimmune Disease Diagnostics Market Size, by Geography
Figure 12 Impact Analysis of Market Dynamics
Figure 13 National Institutes of Health: Research Funding for Autoimmune Diseases, 2021–2024 (USD Million)
Figure 14 Number of People with Type-1 Diabetes, by Country, 2022
Figure 15 Global Prevalence of Multiple Sclerosis Per 100,000 People, 2013 Vs. 2020
Figure 16 U.S.: Research Funding for Multiple Sclerosis, 2018-2024 (USD Million)
Figure 17 Porter’s Five Forces Analysis
Figure 18 EU Regulatory Pathway - IVDR 2017/746
Figure 19 China: Medical Device Registration Flow Chart (SFDA)
Figure 20 Saudi Arabia: Regulatory Landscape/Marketing Approval Process
Figure 21 Global Autoimmune Disease Diagnostics Market, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 22 Global Autoimmune Disease Diagnostics Market, by Test Type, 2024 Vs. 2031 (USD Million)
Figure 23 U.S.: Number of People with Arthritis (Million) (2020-2035)
Figure 24 Global Ageing Population, by Region (2019 Vs. 2030)
Figure 25 Global Autoimmune Disease Diagnostics Market, by Disease Type, 2024 Vs. 2031 (USD Million)
Figure 26 Multiple Sclerosis Global Prevalence Per 100,000 People (2013 Vs. 2020)
Figure 27 Research Funding for Multiple Sclerosis in The U.S., 2018-2024 (USD Million)
Figure 28 Number of People with Type-1 Diabetes (2022)
Figure 29 Research Funding to NIH For Myasthenia Gravis (2018-2024)
Figure 30 Global Autoimmune Disease Diagnostics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 31 Global Autoimmune Disease Diagnostics Market, by Region, 2024 Vs. 2031 (USD Million)
Figure 32 North America: Autoimmune Disease Diagnostics Market Snapshot
Figure 33 Europe: Autoimmune Disease Diagnostics Market Snapshot
Figure 34 Germany: Deaths Due to Musculoskeletal and Connective Tissue Diseases, 2015-2020
Figure 35 U.K.: Number of Cases Type 1 Diabetes (0-19 Years), 2019—2022
Figure 36 Italy: Gpd Percentage Spent on Healthcare, 2015—2021
Figure 37 Spain: Number of People Living with HIV (2010-2021)
Figure 38 Asia-Pacific: Autoimmune Disease Diagnostics Market Snapshot
Figure 39 China: Wheat Consumption (1000 Mt) 2015-2022
Figure 40 Japan: Percentage of Population Aged 65 Years and Above (2010-2030)
Figure 41 Australia: Government Research Expenditure on Immunological Diseases 2017 Vs. 2020 (USD Million)
Figure 42 Colombia: Lupus Cases 2016-2021
Figure 43 Middle East & North Africa: Healthcare Expenditure (% Of GDP) (2014-2020)
Figure 44 Key Growth Strategies Adopted by Leading Players 2020-2023
Figure 45 Autoimmune Disease Diagnostics Market: Competitive Benchmarking by Test Type
Figure 46 Autoimmune Disease Diagnostics Market: Competitive Benchmarking, by Region
Figure 47 Competitive Dashboard: Autoimmune Disease Diagnostics Market
Figure 48 Abbott Laboratories: Financial Overview (2023)
Figure 49 F. Hoffman-La Roche Ltd: Financial Overview (2023)
Figure 50 Siemens Healthineers AG (A Subsidiary of Siemens AG): Financial Overview (2023)
Figure 51 Thermo Fisher Scientific Inc.: Financial Overview (2023)
Figure 52 Bio-Rad Laboratories: Financial Overview (2023)
Figure 53 Danaher Corporation: Financial Overview (2023)
Figure 54 Becton, Dickinson and Company: Financial Overview (2023)
Figure 55 PerkinElmer, Inc.: Financial Overview (2023)
Figure 56 Grifols, S.A.: Financial Overview (2023)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Rapid Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Sep-2024
Europe Molecular Diagnostics Market - Opportunity Analysis and Industry Forecast (2024 -2030)
Published Date: Jul-2024
Livestock Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: May-2024
Tuberculosis Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: May-2024
